Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 2/20 | 0.40 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.40 |
| ▸ | AKT2 | P31751 | 1/20 | 0.40 |
| ▸ | BRD2 | P25440 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 2/20 | 0.39 |
| ▸ | TDO2 | P48775 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 5/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.36 |
| ▸ | NPC1 | O15118 | 3/20 | 0.36 |
| ▸ | RAB9A | P51151 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.36 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13555449 | 0.85 | ALDH1A1 (0.34) | BRD4CHEK1AKT2BRD2L3MBTL1 | |
| SCHEMBL15086106 | 0.82 | ESR1 (0.39) | AKT2L3MBTL1MAPTRAB9AKDM4E | |
| SCHEMBL13555444 | 0.82 | DHFR (0.41) | AKT2L3MBTL1TP53MAPTSMN1; SMN2 | |
| SCHEMBL13228950 | 0.82 | AKT2 (0.39) | BRD4CHEK1AKT2BRD2L3MBTL1 | |
| SCHEMBL14701343 | 0.79 | ESR1 (0.36) | L3MBTL1MAPTSMN1; SMN2KDM4EHTT | |
| SCHEMBL21202691 | 0.79 | ALDH1A1 (0.39) | AKT2L3MBTL1TP53MAPTSMN1; SMN2 | |
| SCHEMBL14515092 | 0.78 | AKT2 (0.37) | BRD4CHEK1AKT2BRD2TDO2 | |
| SCHEMBL19104394 | 0.77 | BRD4 (0.48) | BRD4CHEK1AKT2BRD2L3MBTL1 | |
| SCHEMBL15672183 | 0.76 | MEN1 (0.33) | L3MBTL1MAPTRAB9AKDM4EALDH1A1 | |
| SCHEMBL19104413 | 0.76 | PDPK1 (0.36) | TDO2MAPTSMN1; SMN2NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10367148-B2 | Light-emitting device, electronic apparatus, and inspection method | SEIKO EPSON CORPORATION (JP) | 2019-07-30 | — | — | US | disclosed |
| US-9876177-B2 | Thiadiazole-based compound, light emitting element compound, light emitting element, light emitting device, authentication device, and electronic device | SEIKO EPSON CORPORATION (JP) | 2018-01-23 | — | — | US | disclosed |
| US-9876177-B2 | Thiadiazole-based compound, light emitting element compound, light emitting element, light emitting device, authentication device, and electronic device | SEIKO EPSON CORPORATION (JP) | 2018-01-23 | — | — | US | disclosed |
| US-20170365793-A1 | THIADIAZOLE-BASED COMPOUND, LIGHT EMITTING ELEMENT COMPOUND, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, AUTHENTICATION DEVICE, AND ELECTRONIC DEVICE | SEIKO EPSON CORP (JP) | 2017-12-21 | — | — | US | disclosed |
| US-20170365793-A1 | THIADIAZOLE-BASED COMPOUND, LIGHT EMITTING ELEMENT COMPOUND, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, AUTHENTICATION DEVICE, AND ELECTRONIC DEVICE | SEIKO EPSON CORP (JP) | 2017-12-21 | — | — | US | disclosed |
| US-9401460-B2 | Light emitting element | SEIKO EPSON CORPORATION (JP) | 2016-07-26 | — | — | US | disclosed |
| US-9224928-B2 | Light emitting element, light emitting device and electronic apparatus | SEIKO EPSON CORPORATION (JP) | 2015-12-29 | — | — | US | disclosed |
| US-9159932-B2 | Light emitting element, light emitting device, and electronic device | SEIKO EPSON CORPORATION (JP) | 2015-10-13 | — | — | US | disclosed |
| US-20150236226-A1 | LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE AND ELECTRONIC APPARATUS | SEIKO EPSON CORP (JP) | 2015-08-20 | — | — | US | disclosed |
| US-20140332835-A1 | LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE AND ELECTRONIC APPARATUS | SEIKO EPSON CORPORATION (JP) | 2014-11-13 | — | — | US | disclosed |
| US-8803138-B2 | Light emitting element, light emitting device and electronic apparatus | SEIKO EPSON CORPORATION (JP) | 2014-08-12 | — | — | US | disclosed |
| US-20130168654-A1 | LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE AND ELECTRONIC APPARATUS | SEIKO EPSON CORPORATION (JP) | 2013-07-04 | — | — | US | disclosed |
| US-20130037785-A1 | LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, AND ELECTRONIC DEVICE | SEIKO EPSON CORPORATION (JP) | 2013-02-14 | — | — | US | disclosed |
| US-20120267615-A1 | THIADIAZOLE-BASED COMPOUND, LIGHT EMITTING ELEMENT COMPOUND, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, AUTHENTICATION DEVICE, AND ELECTRONIC DEVICE | SEIKO EPSON CORPORATION (JP) | 2012-10-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10367148-B2 | Light-emitting device, electronic apparatus, and inspection method | CRY1, INF2, CRY2 | BRD4 3448/4885CHEK1 3995/4885AKT2 4640/4885 |
| US-20170365793-A1 | THIADIAZOLE-BASED COMPOUND, LIGHT EMITTING ELEMENT COMPOUND, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, AUTHENTICATION DEVICE, AND ELECTRONIC DEVICE | CYP2C19, CYP2C9, CYP1A2 | BRD4 349/4885CHEK1 2883/4885AKT2 4630/4885 |
| US-20120267615-A1 | THIADIAZOLE-BASED COMPOUND, LIGHT EMITTING ELEMENT COMPOUND, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, AUTHENTICATION DEVICE, AND ELECTRONIC DEVICE | CYP2C19, CYP2C9, AADAC | BRD4 290/4885CHEK1 2935/4885AKT2 4656/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.